drugset
drugset / Trial / NCT03966170

Citicoline as Neuroprotector in Preterm

NCT03966170 ↗

Phase 3 Recruiting 40 enrolled Tanta University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Citicoline as neuroprotector in preterm

Timeline

Start
2019-05-01
Primary completion
2028-11
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Citicoline Other / unclassified — —

Indications

No indication recorded.